These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2990677)
1. Stability of vincristine complexes in cytosols derived from xenografts of human rhabdomyosarcoma and normal tissues of the mouse. Houghton JA; Williams LG; Houghton PJ Cancer Res; 1985 Aug; 45(8):3761-7. PubMed ID: 2990677 [TBL] [Abstract][Full Text] [Related]
2. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins. Houghton JA; Houghton PJ; Hazelton BJ; Douglass EC Cancer Res; 1985 Jun; 45(6):2706-12. PubMed ID: 3986804 [TBL] [Abstract][Full Text] [Related]
3. Influence of guanine nucleotides on vincristine binding in tumor cytosols and purified tubulin: evidence for an inhibitor of vincristine binding. Bowman LC; Houghton JA; Houghton PJ J Cell Physiol; 1990 Sep; 144(3):376-82. PubMed ID: 2391373 [TBL] [Abstract][Full Text] [Related]
4. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas. Houghton JA; Williams LG; Torrance PM; Houghton PJ Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363 [TBL] [Abstract][Full Text] [Related]
5. GTP influences the binding of vincristine in human tumor cytosols. Bowman LC; Houghton JA; Houghton PJ Biochem Biophys Res Commun; 1986 Mar; 135(3):695-700. PubMed ID: 3964272 [TBL] [Abstract][Full Text] [Related]
6. Formation and stability of vincristine-tubulin complex in kidney cytosols. Role of GTP and GTP hydrolysis. Bowman LC; Houghton JA; Houghton PJ Biochem Pharmacol; 1988 Apr; 37(7):1251-7. PubMed ID: 3355599 [TBL] [Abstract][Full Text] [Related]
7. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard. Horton JK; Houghton PJ; Houghton JA Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432 [TBL] [Abstract][Full Text] [Related]
8. Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids. Houghton JA; Williams LG; Dodge RK; George SL; Hazelton BJ; Houghton PJ Biochem Pharmacol; 1987 Jan; 36(1):81-8. PubMed ID: 3541941 [TBL] [Abstract][Full Text] [Related]
9. Scheduling of vincristine: drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration. Houghton JA; Meyer WH; Houghton PJ Cancer Treat Rep; 1987; 71(7-8):717-21. PubMed ID: 3607783 [TBL] [Abstract][Full Text] [Related]
10. Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids. Pain J; Sirotnak FM; Barrueco JR; Yang CH; Biedler JL J Cell Physiol; 1988 Aug; 136(2):341-7. PubMed ID: 3045133 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate? Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524 [TBL] [Abstract][Full Text] [Related]
12. Distribution and metabolism of vincristine in mice, rats, dogs, and monkeys. El Dareer SM; White VM; Chen FP; Mellet LB; Hill DL Cancer Treat Rep; 1977 Oct; 61(7):1269-77. PubMed ID: 412588 [TBL] [Abstract][Full Text] [Related]
13. Disruption of microtubules in vivo by vincristine induces large membrane complexes and other cytoplasmic abnormalities in megakaryocytes and platelets of normal rats like those in human and Wistar Furth rat hereditary macrothrombocytopenias. Stenberg PE; McDonald TP; Jackson CW J Cell Physiol; 1995 Jan; 162(1):86-102. PubMed ID: 7814453 [TBL] [Abstract][Full Text] [Related]
15. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice]. Chen T; Hou SX; Wang YY; Zhang WS; Chen DH Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615 [TBL] [Abstract][Full Text] [Related]
16. Stabilization of labile glucocorticoid-receptor complexes from acute nonlymphocytic leukemia cells by a factor from chronic lymphocytic leukemia cells. Holbrook NJ; Bloomfield CD; Munck A Cancer Res; 1984 Jan; 44(1):407-14. PubMed ID: 6690056 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts. Eiseman JL; Lan J; Lagattuta TF; Hamburger DR; Joseph E; Covey JM; Egorin MJ Cancer Chemother Pharmacol; 2005 Jan; 55(1):21-32. PubMed ID: 15338192 [TBL] [Abstract][Full Text] [Related]
18. Partial characterization of specific cantharidin binding sites in mouse tissues. Graziano MJ; Pessah IN; Matsuzawa M; Casida JE Mol Pharmacol; 1988 Jun; 33(6):706-12. PubMed ID: 3380085 [TBL] [Abstract][Full Text] [Related]
19. Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts. Horton JK; Thimmaiah KN; Houghton JA; Horowitz ME; Houghton PJ Biochem Pharmacol; 1989 Jun; 38(11):1727-36. PubMed ID: 2735930 [TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]